Ozempic
-
healthEarly Research Suggests Weight Loss Drugs Like Ozempic Could Be Longevity Drugs
Initial studies on GLP-1 medications indicate they may slow biological aging and combat diseases of aging, though experts warn the data is preliminary and not for the metabolically healthy.
-
healthHow a 1922 Rescue Mission Explains Ozempic’s $969 US vs. €59 German Price
The identical semaglutide pen costs sixteen times more in the US than in Germany. The price gap traces back to a Canadian discovery, a Danish foundation, and America's unique pharmacy-benefit system.
-
healthFrom Lizard Venom to National Phenomenon: How GLP-1 Drugs Reached One in Eight Americans
A Bronx endocrinologist’s discovery in Gila monster saliva, initially rejected by the government, spawned a class of drugs now used by roughly one in eight U.S. adults for weight loss and diabetes.
-
healthWhy Ozempic Fails for Some Patients: Stanford Uncovers a Genetic Resistance
New research from Stanford indicates that a specific genetic variant in the PAM enzyme causes biological resistance to GLP-1 drugs like Ozempic, impacting blood sugar control.
-
healthGLP-1 Weight Loss Drugs Drive Surge in Cosmetic Body Contouring Procedures
Rapid weight loss from GLP-1 medications like Ozempic is causing sagging skin and volume loss, prompting a significant increase in plastic surgery and body contouring procedures nationwide.
-
healthGLP-1 Users Reduce Physical Activity Despite Muscle Loss Risks
New research presented at ENDO 2026 reveals GLP-1 users significantly decrease exercise, risking lean muscle mass. Experts emphasize mandatory resistance training and clinical oversight for safe weight management.
-
healthGLP-1 Drugs Linked to Lower Breast Cancer Risk and Better Outcomes
Observational studies show GLP-1 meds like Ozempic may reduce breast cancer incidence by 30% and improve survival rates.
-
healthGLP-1 Drugs May Cut Breast Cancer Risk by 30%, Study Finds
GLP-1 medications like Ozempic and Mounjaro may reduce breast cancer risk by up to 30%, independent of weight loss, new research shows.